Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Chandler Macleod Group Ltd Acquires Vivir Healthcare


Tuesday, 4 Dec 2012 08:13pm EST 

Chandler Macleod Group Ltd announced that it has entered into a binding agreement to acquire 100% of the shares in Vivir Healthcare Pty Ltd (Vivir) for AUD 34.6 million. In addition, an earn out payment is potentially payable depending on the financial performance of Vivir in the 2014 financial year. The transaction, to be funded by term debt, is scheduled to complete December 5, 2012. The business is expected to contribute between AUD 3.0 million and AUD 4.0 million to Chandler Macleod’s profit before tax in the second half of the 2013 financial year (before transaction funding costs and amortisation of acquired intangibles). It is forecast to contribute between AUD 9.0 million and AUD 11.0 million on the same basis in the 2014 financial year. 

Company Quote

0.325
-0.0050 -1.52%
11 Jul 2014